232 related articles for article (PubMed ID: 12891467)
21. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
[TBL] [Abstract][Full Text] [Related]
22. Decreased levels of PAI-1 and alpha 2-antiplasmin contribute to enhanced fibrinolytic activity in divers.
Radziwon P; Olszański R; Tomaszewski R; Lipska A; Dabrowiecki Z; Korzeniewski K; Siermontowski P; Boczkowska-Radziwon B
Thromb Res; 2007; 121(2):235-40. PubMed ID: 17521709
[TBL] [Abstract][Full Text] [Related]
23. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of coagulation-fibrinolysis factors in normal pregnancy, labor and puerperium and in cesarean section delivery.
Tei A; Mutoh S; Yaoi Y; Saito M
Bull Tokyo Med Dent Univ; 1989 Jun; 36(2):19-26. PubMed ID: 2776281
[TBL] [Abstract][Full Text] [Related]
25. The influence of L-asparaginase therapy on the fibrinolytic system.
Vellenga E; Kluft C; Mulder NH; Wijngaards G; Nieweg HO
Br J Haematol; 1984 Jun; 57(2):247-54. PubMed ID: 6203549
[TBL] [Abstract][Full Text] [Related]
26. Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes.
Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
Am J Perinatol; 1998 Aug; 15(8):479-86. PubMed ID: 9788646
[TBL] [Abstract][Full Text] [Related]
27. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
[TBL] [Abstract][Full Text] [Related]
28. [Activation of fibrynolysis in children with chronic B or C hepatitis].
Michalska K; Szaflarska-Popławska A; Dymek G; Kotschy M
Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
[TBL] [Abstract][Full Text] [Related]
29. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
Homma T; Ichikawa T
Biochem Exp Biol; 1979; 15(3):229-36. PubMed ID: 122165
[TBL] [Abstract][Full Text] [Related]
30. [Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor].
Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):86-8. PubMed ID: 8756739
[TBL] [Abstract][Full Text] [Related]
31. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
32. Vitamin E improves fibrinolytic activity in patients with coronary spastic angina.
Miyamoto S; Kawano H; Takazoe K; Soejima H; Sakamoto T; Hokamaki J; Yoshimura M; Nakamura H; Yodoi J; Ogawa H
Thromb Res; 2004; 113(6):345-51. PubMed ID: 15226088
[TBL] [Abstract][Full Text] [Related]
33. Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
Koh SC; Anandakumar C; Biswas A; Fong YF
Thromb Haemost; 2002 Jan; 87(1):175-6. PubMed ID: 11858184
[No Abstract] [Full Text] [Related]
34. Effects of minimal dose aprotinin on blood loss and fibrinolytic system-complement activation in coronary artery bypass grafting surgery.
Cicekcioglu F; Cagli K; Emir M; Topbas M; Catav Z; Sener E; Tasdemir O
J Card Surg; 2006; 21(4):336-41. PubMed ID: 16846409
[TBL] [Abstract][Full Text] [Related]
35. [Effects of chronic mercury poisoning on blood coagulation and fibrinolysis systems].
Song YG
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Dec; 23(6):405-7. PubMed ID: 16405768
[TBL] [Abstract][Full Text] [Related]
36. Aprotinin inhibits tissue plasminogen activator-mediated fibrinolysis during orthotopic liver transplantation.
Cottam S; Hunt B; Segal H; Ginsburg R; Potter D
Transplant Proc; 1991 Jun; 23(3):1933. PubMed ID: 1712135
[No Abstract] [Full Text] [Related]
37. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
[TBL] [Abstract][Full Text] [Related]
38. Fibrinolytic activity in dogs after surgically induced trauma.
Lanevschi A; Kramer JW; Greene SA; Meyers KM
Am J Vet Res; 1996 Aug; 57(8):1137-40. PubMed ID: 8836363
[TBL] [Abstract][Full Text] [Related]
39. Regular alcohol intake and fibrinolysis.
van Golde PM; Hart HCh; Kraaijenhagen RJ; Bouma BN; van de Wiel A
Neth J Med; 2002 Aug; 60(7):285-8. PubMed ID: 12430575
[TBL] [Abstract][Full Text] [Related]
40. [Progress in the detection of intravascular activation of fibrinolysis].
Zawilska K
Acta Haematol Pol; 1995; 26(1):33-8. PubMed ID: 7747560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
